Subscribe Sign In Register

Pharmaceuticals

2016-03-09-da-bernie-sanders-large.jpg
Portfolio
Daily Agenda: Debating the Oil Rally
Andrew Barber
March 9, 2016
2016-03-vitaliy-katsenelson-gilead-sciences-lab-worker-large.jpg
Portfolio
Gilead Sciences’ Miracle Drug Combination
Vitaliy Katsenelson
February 23, 2016
2016-02-da-oil-glut-ohio-pumps-large.jpg
Portfolio
Daily Agenda: Oil Market Continues to Feel Supply Glut
Andrew Barber
February 9, 2016
2016-02-gmtl-ab-volatility-spike-chart1.jpg
Portfolio
Riding Out Wild Equity Markets
Kent Hargis
February 3, 2016
2015-12-anne-szustek-deals-of-the-year-allergan-pfizer-large.jpg
Portfolio
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
December 16, 2015
Inside Gilead Sciences Inc.
Portfolio
Specialty Pharma Drugs Raise Difficult Issues
Khadijah M Silver
December 15, 2015
2015-11-kaitlin-ugolik-andrew-lo-large.jpg
Portfolio
MIT’s Andrew Lo Touts Megafund to Tackle Cancer, Rare Diseases
Kaitlin Ugolik
October 26, 2015
2015-10-jess-delaney-kyle-bass-large.jpg
Portfolio
Hedge Fund Manager Kyle Bass Declares War on Drug Prices
Jess Delaney
October 22, 2015
2015-10-tom-johnson-res-aart-rising-stars-wes-golladay-jessica-fye-joseph-denardi-vamil-divan-paul-matteis-nicholas-del-deo-large.jpg
Research
2015 All-America Research Team: Meet the Rising Stars
Carolyn Koo
October 13, 2015
Martin Shkreli, Chief Investment Officer of MSMB Capital Management
Portfolio
Pharmaceutical Companies Gird for Drug-Price Reckoning
Kaitlin Ugolik
October 8, 2015
2015-09-kaitlin-ugolik-vivek-ramaswamy-large.jpg
Portfolio
Axovant’s Vivek Ramaswamy Aims to Reinvent Dementia Treatment
Kaitlin Ugolik
September 8, 2015
2015-07-da-chinese-yuan-flip-large.jpg
Portfolio
Daily Agenda: Gravity Returns to Chinese Stock Market
Andrew Barber
July 27, 2015